Fundraising Fox
Cullinan Oncology
Founded 2016 · 128 employees on LinkedIn · 5 known investors
Find your way into Cullinan Oncology
Sign up to see every warm intro you have to Cullinan Oncology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cullinan Oncology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cullinan Therapeutics develops clinical-stage T cell engager therapies targeting autoimmune diseases and cancer, leveraging immune modulation expertise to advance high-impact therapeutic candidates.
Investors · 5
Lilly Asia Ventureslisted by Lilly Asia VenturesHong Kongvia Hongbo Lu · inferred
How we know: the VCSheet dataset · Not right? Tell us
MPM BioImpactlisted by MPM BioImpactBoston · $1M – $15M
How we know: MPM BioImpact's portfolio page · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BJun 2020Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 3
Cullinan TherapeuticsCullinan Therapeutics is a clinical-stage biotech company developing therapeutic molecules for autoimmune diseases and cancer, with expertise in immune modulation. The company focuses on first- or best-in-class treatments to improve outcomes for patients managing these conditions.
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
TargetedoncTargeted Oncology is a medical news and education publication for oncologists and cancer care professionals, covering clinical trial data, FDA approvals, treatment guidelines, and expert commentary across cancer types. It delivers conference coverage, podcasts, videos, and short-form content focused on precision oncology and targeted cancer therapies.
Companies working in the same space as Cullinan Oncology.
Frequently asked questions
- What does Cullinan Oncology do?
- Cullinan Therapeutics develops clinical-stage T cell engager therapies targeting autoimmune diseases and cancer, leveraging immune modulation expertise to advance high-impact therapeutic candidates.
- Who are Cullinan Oncology's investors?
- Cullinan Oncology's investors include LAV, Lilly Asia Ventures, MPM BioImpact, Schooner Capital, Taiho Ventures, LLC.